Insmed (NASDAQ:INSM) PT Raised to $67.00
Insmed (NASDAQ:INSM – Free Report) had its price target boosted by TD Cowen from $45.00 to $67.00 in a report released on Wednesday, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently weighed in on INSM. Guggenheim raised their price objective on […]
More Stories
Small Reactor Innovations Spur Global Interest in Nuclear Energy
By John Haughey Few Paris Climate Accord nations are meeting decarbonization goals, but with 31—including the United States—signing onto a...
Ardmore Road Asset Management LP Makes New Investment in Amazon.com, Inc. (NASDAQ:AMZN)
Ardmore Road Asset Management LP purchased a new position in Amazon.com, Inc. (NASDAQ:AMZN) during the 4th quarter, according to its...
Trump’s 25 Percent Auto Part Tariff Goes Into Effect
By Tom Ozimek A 25 percent tariff on imported automobile parts took effect on May 3, marking a significant step...
Renaissance Technologies LLC Has $593,000 Stock Holdings in Alphabet Inc. (NASDAQ:GOOGL)
Renaissance Technologies LLC trimmed its holdings in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 99.6% during the fourth...
Amazon.com, Inc. (NASDAQ:AMZN) Shares Bought by Creekmur Asset Management LLC
Creekmur Asset Management LLC boosted its holdings in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 14.3% in the fourth quarter, HoldingsChannel.com...
Huntington National Bank Grows Stock Holdings in Amazon.com, Inc. (NASDAQ:AMZN)
Huntington National Bank raised its holdings in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 3.6% in the fourth quarter, according to...